SenesTech (NASDAQ:SNES) is scheduled to release its earnings data after the market closes on Tuesday, November 12th. Individual that are interested in participating in the company’s earnings conference call can do so using this link.
SenesTech (NASDAQ:SNES) last released its earnings results on Tuesday, August 13th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.10) by $0.01. The firm had revenue of $0.02 million during the quarter. SenesTech had a negative return on equity of 169.12% and a negative net margin of 3,432.63%. On average, analysts expect SenesTech to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
NASDAQ:SNES opened at $0.68 on Friday. SenesTech has a 12-month low of $0.55 and a 12-month high of $1.95. The company has a current ratio of 3.73, a quick ratio of 2.60 and a debt-to-equity ratio of 0.07. The firm has a market cap of $20.09 million, a PE ratio of -1.08 and a beta of 1.83. The stock has a fifty day moving average price of $0.84 and a 200 day moving average price of $1.29.
In other news, insider Cheryl Ann Dyer sold 40,000 shares of the business’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $1.19, for a total value of $47,600.00. Following the completion of the sale, the insider now directly owns 391,165 shares of the company’s stock, valued at approximately $465,486.35. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold a total of 52,000 shares of company stock valued at $58,160 over the last three months. Company insiders own 10.91% of the company’s stock.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.
Featured Story: What moving averages are used to define a golden cross?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.